EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study

Fleur Veldman iD, Francesco Innocenti iD, Imran Aziz iD, Asma Fikree, Shrikant I Bangdiwala, Olafur Palsson, Ami D Sperber, Daniel Keszthelyi

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70756 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2026. Written by Fleur Veldman and 7 co-authors. Institution: Department of Gastroenterology-Hepatology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Med…. Major MEDLINE topics: Fatigue, Brain-Gut Axis. Cited 1 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Horizon Europe Grant ERC-2022-STG RESILIENCE.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Overlap among disorders of gut‐brain interaction (DGBI) is common, with many patients experiencing concomitant non‐gastrointestinal symptoms. Fatigue is frequently reported, yet population‐based prevalence estimates across DGBI are limited.

Aims

To examine the prevalence and burden of fatigue among DGBI.

Methods

Data were derived from the Rome Foundation Global Epidemiology Study's internet‐based survey, conducted in 26 countries using the Rome IV Adult Diagnostic Questionnaire. Fatigue was assessed with single items from the Patient‐Reported Outcomes Measurement Information System (PROMIS) Global‐10 and the Patient Health Questionnaire‐12 (PHQ‐12). Prevalence of fatigue was compared across three groups, including no DGBI, one DGBI and multiple DGBI, with potential associated factors examined using logistic regression.

Results

Among 54,127 participants (49% female; mean age 44 years), 59.9% had no DGBI, 26.6% had one DGBI and 13.5% had multiple DGBI. Fatigue prevalence was higher with more DGBI overlap: PROMIS 7.7% (95% CI:7.46–8.04), 16.4% (95% CI: 15.79–17.00), 30.2% (95% CI: 29.16–31.26); PHQ‐12 12.6% (95% CI: 12.24–12.96), 25.8% (95% CI: 25.06–26.49), 42.0% (95% CI: 40.83–43.09) for no, one, and multiple DGBI. Fatigue was most common in reflux hypersensitivity (PROMIS 46%, PHQ‐12 58%) and irritable bowel syndrome (PROMIS 39%, PHQ‐12 53%). Among individuals with DGBI, fatigue was consistently associated across both definitions with female sex, age, BMI, sleep disturbance, higher anxiety and depression scores, greater somatic symptom burden, lower psychological well‐being, antidepressant use, and satiety, abdominal pain, and bloating.

Conclusions

Fatigue is common and burdensome in DGBI, particularly with overlapping diagnoses. Given the cross‐sectional design, directionality between fatigue and DGBI symptom burden remains unclear. Future research should employ longitudinal fatigue assessments to inform targeted management.

Subjects

MeSH terms (MEDLINE)

FatigueBrain-Gut AxisHumansFemalePrevalenceAdultMaleMiddle AgedSurveys and QuestionnairesSymptom BurdenIrritable Bowel SyndromeCross-Sectional Studies

Author keywords

disorders of gut–brain interactionepidemiologyfatigueillness burden

Authors and institutions

  • Department of Gastroenterology-Hepatology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Department of Methodology and Statistics, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
  • Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • GI Physiology Unit, University College London Hospital NHS Foundation Trust, London, UK.
  • Division of Surgery & Interventional Science, Research Department of Targeted Intervention, University College London, London, UK.

ORCID profiles: Fleur Veldman, Francesco Innocenti, Imran Aziz

Funding

  • Horizon Europe Grant ERC-2022-STG RESILIENCE

Cite

APA

Veldman, F., Innocenti, F., Aziz, I., Fikree, A., Bangdiwala, S. I., Palsson, O., Sperber, A. D., & Keszthelyi, D. (2026). Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70756

Vancouver

Veldman F, Innocenti F, Aziz I, Fikree A, Bangdiwala SI, Palsson O, et al. Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70756

BibTeX
@article{Veldman2026,
  author = {Veldman, Fleur and Innocenti, Francesco and Aziz, Imran and Fikree, Asma and Bangdiwala, Shrikant I and Palsson, Olafur and Sperber, Ami D and Keszthelyi, Daniel},
  title = {Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70756}
}
Start for free →